article thumbnail

FDA Moving to Nonanimal Testing Methodologies in Preclinical Research

Pharmacy Times

Updated February 26, 2016. The goal over the next 5 years is to shift from animal testing being a requirement to being an exception. 3,6 REFERENCES FDA drug approval process infographic (horizontal). Accessed June 19, 2025. link] Consolidated Appropriations Act of 2023, HR 2617, 117th Cong (2023). Accessed June 23, 2025.

article thumbnail

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

The 2016 World Health Organization classification of MCL recognizes 2 molecular subtypes that reflect divergent pathogenesis and clinical behavior 2 : Classical MCL is derived from naive B cells that lack somatic hypermutation in IGHV , do not transit through the germinal center, and express the SOX11 transcription factor.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025

Pharmacy Times

Within the pharmacy, the average appointment time for contraception prescribing is just 20 minutes, and Meredith highlighted the importance of involving pharmacy technicians to streamline the workflow. 1 Meredith also cited promising outcomes from states like Oregon.

article thumbnail

Lumateperone Submits Application for Schizophrenia Indication to FDA for Supplemental New Drug

Pharmacy Times

FDA for CAPLYTA® (lumateperone) with data demonstrating significant schizophrenia relapse prevention compared to placebo. July 8, 2025. Nasrallah, H. Bossie, C. Hough, D., & & Turkoz, I. Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy.

article thumbnail

Invest a Few Minutes in Inhaler Counseling

Pharmacy Times

doi:10.1183/13993003.01794-2016 Leving MT, Kocks J, Bosnic-Anticevich S, Dekhuijzen R, Usmani OS. Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients. Eur Respir J. 2017;49(2):1601794.

article thumbnail

Zanubrutinib Linked to Lower Infection Risk Than Venetoclax Plus Obinutuzumab in Real-World CLL/SLL Study

Pharmacy Times

1,2 To better understand this relationship, researchers assessed 4754 patients with CLL/SLL who were treated with either venetoclax and obinutuzumab from April 2016 to August 2022 (n = 2104) or zanubrutinib from November 2019 to August 2023 (n = 2650).

article thumbnail

Investigating the Pharmacist’s Role in Psychedelic-Assisted Psychotherapy for Patients With Cancer

Pharmacy Times

Ross et al published a landmark study in 2016 evaluating psilocybin’s impact on anxiety and depression in 51 patients with life-threatening cancer. It triggered an outflow of new psychedelic research interest and added evidence to the relationship between mystical experience and the efficacy of psilocybin.